Michael Bergmann Selected Research

Michael Bergmann Research Topics

Disease

31	Neoplasms (Cancer) 01/2023 - 04/2005
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2012
5	Crohn Disease (Crohn's Disease) 01/2023 - 01/2018
5	Rectal Neoplasms (Rectal Cancer) 01/2020 - 04/2002
4	Infections 01/2020 - 07/2010
4	Breast Neoplasms (Breast Cancer) 01/2020 - 03/2013
3	Inflammation (Inflammations) 03/2024 - 11/2016
3	Neoplasm Metastasis (Metastasis) 11/2018 - 02/2006
3	Sepsis (Septicemia) 11/2009 - 09/2002
2	Colonic Neoplasms (Colon Cancer) 01/2023 - 09/2010
2	Carcinogenesis 01/2023 - 10/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2022 - 11/2022
2	Diabetes Mellitus 01/2021 - 01/2018
2	Disease Progression 03/2018 - 12/2013
2	Melanoma (Melanoma, Malignant) 12/2017 - 02/2006
2	Septic Shock (Toxic Shock Syndrome) 12/2003 - 09/2002
1	COVID-19 03/2024
1	Fibrosis (Cirrhosis) 01/2023
1	Peritoneal Neoplasms 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Wilms Tumor (Wilm's Tumor) 09/2021
1	Neuroblastoma 09/2021
1	Hypoglycemia (Reactive Hypoglycemia) 01/2021
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2021
1	Pathologic Constriction (Stenosis) 10/2020
1	Glioma (Gliomas) 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020
1	Ascites 10/2019
1	Colitis 10/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2018
1	Heart Failure 03/2018
1	Hyperglycemia 01/2018
1	Bites and Stings (Sting) 01/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2017
1	Aneurysm (Aneurysms) 12/2017

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2006
7	Biomarkers (Surrogate Marker)IBA 09/2021 - 03/2013
6	CytokinesIBA 12/2022 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 04/2005
2	AntigensIBA 12/2022 - 01/2022
2	Insulin (Novolin)FDA Link 01/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2012
2	Therapeutic UsesIBA 01/2020 - 12/2017
2	human ERBB2 proteinIBA 01/2020 - 12/2013
2	Monoclonal AntibodiesIBA 01/2020 - 12/2013
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 12/2013
2	RNA (Ribonucleic Acid)IBA 10/2019 - 01/2018
2	Epirubicin (Ellence)FDA LinkGeneric 01/2016 - 03/2013
2	HMGB1 Protein (HMG1)IBA 01/2016 - 03/2013
2	Docetaxel (Taxotere)FDA Link 01/2016 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 12/2003
2	CatecholaminesIBA 12/2003 - 09/2002
1	LigandsIBA 03/2024
1	torinIBA 01/2023
1	MK 2206IBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	AZD 6244IBA 01/2023
1	GalliumIBA 01/2023
1	68Ga-FAPIIBA 01/2023
1	Immunoglobulin G (IgG)IBA 12/2022
1	Immune Checkpoint InhibitorsIBA 11/2022
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 11/2022
1	Chemotactic FactorsIBA 01/2022
1	mesoglycanIBA 09/2021
1	ORALIT (ORS)IBA 01/2021
1	2- (2- methyl- 4- chlorophenylamino)- 2- imidazoline (CDMI)IBA 10/2020
1	RibonucleoproteinsIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	CalreticulinIBA 01/2020
1	OsteopontinIBA 10/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2019
1	Cysteine (L-Cysteine)FDA Link 09/2019
1	Messenger RNA (mRNA)IBA 09/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	SurvivinIBA 01/2019
1	HLA-DR Antigens (HLA-DR)IBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 11/2018
1	Tumor Biomarkers (Tumor Markers)IBA 11/2018
1	AlbuminsIBA 01/2018
1	Interferon Type IIBA 01/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2017
1	TrypsinIBA 12/2017
1	Pancreatic Elastase (Elastase)IBA 12/2017

Therapy/Procedure

17	Therapeutics 01/2023 - 07/2010
7	Neoadjuvant Therapy 11/2022 - 01/2011
6	Immunotherapy 11/2022 - 01/2009
3	Drug Therapy (Chemotherapy) 09/2021 - 12/2013
3	Radiotherapy 01/2020 - 04/2002
2	Kidney Transplantation 01/2021 - 01/2018
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Cytoreduction Surgical Procedures 01/2023
1	Precision Medicine 01/2022
1	Transplantation 01/2021
1	Biological Therapy 01/2020
1	Ileostomy 01/2020
1	Colostomy 01/2020
1	Antibiotic Prophylaxis 03/2019
1	Minimally Invasive Surgical Procedures 03/2019
1	Chemoradiotherapy 01/2019